Latest Announcements

BSE & NSE corporate filings with AI summaries

BSECompany Update▲ PositiveProduct Launch3 Aug 2026

Biocon Ltd

Press Release

Biocon Ltd has announced the commercial launch of Yesafili, a biosimilar to Eylea 2 mg, in the United States. The product is a vascular endothelial growth factor (VEGF) inhibitor used to treat various types of ophthalmology conditions.

Read more →📎 1 attachment
BSECompany Update▲ PositiveOrder Win3 Aug 2026

Biocon Ltd

Commercial Launch of Product

Biocon Ltd has commercially launched Yesafili, a biosimilar Aflibercept, in the United States, expanding its global presence in ophthalmology and increasing access to life-changing medicines for patients with eye conditions.

Read more →📎 1 attachment
BSEBoard MeetingResults2 Aug 2026

Power Mech Projects Ltd

Power Mech Projects Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 08/08/2026 ,inter alia, to consider and approve the Un-Audited Financial ....

Power Mech Projects Ltd has informed BSE that the meeting of the Board of Directors is scheduled on August 8, 2026, to consider and approve the Un-Audited Financial Results (Standalone and Consolidated) for the first quarter ended June 30, 2026, along with other regular corporate matters.

Read more →📎 1 attachment
BSECompany Update▲ PositiveResults2 Aug 2026

Epack Prefab Technologies Ltd

Intimation under Regulation 30 of the SEBI Listing Regulations, 2015 (Investor Presentation)

Epack Prefab Technologies Ltd has announced its unaudited financial results for the quarter ended June 30, 2026, with revenue growth of 23.9% YoY to ₹3,658 Mn, EBITDA growth of 11.7% YoY to ₹345 Mn, and PAT growth of 13.8% YoY to ₹182 Mn. The company's order book has increased by 40.4% YoY to ₹13,764 Mn. The management has reaffirmed its A+ credit rating and expressed confidence in the company's future growth prospects.

Read more →📎 1 attachment
← PreviousPage 2339 of 3070Next →